Silymarin is used to treat NAFLD and other endoplasmic reticulum stress disorders by lowering the number of ER stress-related proteins such as glucose-regulating protein 78 kDa (GRP78) and X-box-binding protein-1 (XBP-1) [56]. This evidence concerns the gene HSPA5 and metabolic dysfunction-associated steatotic liver disease.